Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00582881 · ClinicalTrials.gov registry record
Characteristics and Disease Progression of Mixed Connective Tissue Disease and Systemic Lupus Erythematosus
A clinical trial, sponsored by University of Miami.
- Completed
- Registry status
- 124
- Enrollment target
NCT00582881: Completed study, sponsored by University of Miami.
NCT00582881 is a clinical trial that has completed, run by University of Miami. The registered enrollment target is 124 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00582881 has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- 124 participants
- Enrollment target
Study Summary
Systemic lupus erythematosus (SLE) and mixed connective tissue disease (MCTD) are long-term autoimmune diseases in which the immune system attacks parts of the body. The abnormal immune reaction causes inflammation of and damage to various body parts and can affect joints, skin, kidneys, heart, lungs, blood vessels, and the brain. SLE and MCTD often affect young women, especially black and Hispanic women, and there is no known cure. Knowing more about SLE and MCTD will help in developing new and effective treatments. The purpose of this study is to characterize immune system abnormalities, genetic components, and disease progression in people with SLE and MCTD.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 124 participants |
| Start Date | 2007-10 |
| Est. Completion | 2025-06-27 |
What the finished NCT00582881 record still lists
NCT00582881 is an observational study that tracks outcomes without assigning an intervention. The registered 124 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00582881 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00582881 about?
NCT00582881 is a clinical study titled "Characteristics and Disease Progression of Mixed Connective Tissue Disease and Systemic Lupus Erythematosus". Systemic lupus erythematosus (SLE) and mixed connective tissue disease (MCTD) are long-term autoimmune diseases in which the immune system attacks parts of the body. The abnormal immune reaction causes inflammation of and damage to various body parts and can affect joints, skin, kidneys, heart, lung...
What is the current status of trial NCT00582881?
This trial is currently completed. The enrollment target is 124 participants. The study started on 2007-10. Estimated completion is 2025-06-27.
Who is sponsoring clinical trial NCT00582881?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523014 · 124 participants · Phase 2
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
- NCT02670707 · 124 participants · Phase 3
Vinblastine/Prednisone Versus Single Therapy With Cytarabine for Langerhans Cell Histiocytosis (LCH)
- NCT02830724 · 124 participants · Phase 1
Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers
- NCT04748809 · 124 participants · NA
Effect of Anti-inflammatory Diet in Rheumatoid Arthritis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia